Calton & Associates’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.09M Sell
5,857
-319
-5% -$59.2K 0.19% 98
2025
Q1
$1.29M Buy
6,176
+2,615
+73% +$548K 0.3% 70
2024
Q4
$633K Sell
3,561
-847
-19% -$151K 0.28% 87
2024
Q3
$871K Buy
4,408
+804
+22% +$159K 0.33% 67
2024
Q2
$618K Sell
3,604
-383
-10% -$65.7K 0.31% 78
2024
Q1
$726K Sell
3,987
-979
-20% -$178K 0.35% 70
2023
Q4
$770K Buy
4,966
+2,393
+93% +$371K 0.31% 74
2023
Q3
$384K Sell
2,573
-2,291
-47% -$342K 0.56% 47
2023
Q2
$655K Sell
4,864
-69
-1% -$9.3K 0.31% 79
2023
Q1
$786K Buy
4,933
+61
+1% +$9.72K 0.36% 68
2022
Q4
$787K Buy
4,872
+681
+16% +$110K 0.3% 77
2022
Q3
$562K Sell
4,191
-251
-6% -$33.7K 0.32% 79
2022
Q2
$680K Sell
4,442
-1,132
-20% -$173K 0.38% 68
2022
Q1
$903K Sell
5,574
-665
-11% -$108K 0.27% 99
2021
Q4
$844K Sell
6,239
-2,579
-29% -$349K 0.23% 119
2021
Q3
$951K Sell
8,818
-776
-8% -$83.7K 0.21% 121
2021
Q2
$1.08M Sell
9,594
-944
-9% -$107K 0.21% 102
2021
Q1
$1.14M Sell
10,538
-8,998
-46% -$973K 0.22% 88
2020
Q4
$2.09M Sell
19,536
-5,589
-22% -$599K 0.37% 54
2020
Q3
$2.2M Buy
25,125
+1,623
+7% +$142K 0.45% 47
2020
Q2
$2.31M Buy
23,502
+13,688
+139% +$1.34M 0.5% 44
2020
Q1
$748K Sell
9,814
-109
-1% -$8.31K 0.19% 105
2019
Q4
$879K Buy
9,923
+3
+0% +$266 0.18% 105
2019
Q3
$751K Buy
9,920
+633
+7% +$47.9K 0.17% 108
2019
Q2
$675K Buy
9,287
+270
+3% +$19.6K 0.19% 91
2019
Q1
$727K Sell
9,017
-1,005
-10% -$81K 0.22% 85
2018
Q4
$924K Sell
10,022
-2,571
-20% -$237K 0.34% 60
2018
Q3
$1.19M Buy
12,593
+472
+4% +$44.6K 0.35% 52
2018
Q2
$1.14M Sell
12,121
-10,940
-47% -$1.03M 0.33% 55
2018
Q1
$2.18M Buy
23,061
+3,891
+20% +$368K 0.63% 27
2017
Q4
$2.02M Buy
+19,170
New +$2.02M 0.51% 30